Chenghui Liao

Chenghui Liao

Auto-generated profile, based on publicly available information

Chenghui Liao

Guangdong Provincial Key Laboratory of Infection Immunity and Inflammation, Department of Physiology and Immunology, School of Basic Medical Sciences, International Cancer Center, Shenzhen University Medical School, Shenzhen University, Shenzhen, China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2026 in Journal of Experimental Medicine
Verified
Journal Article
Open access
YZYunfeng Zhou
Yunfeng Zhou
YZYing Zhang
Ying Zhang
MZMiao Zhu
Miao Zhu
CLChenghui Liao
Chenghui Liao
WLWeie Li
Weie Li
LYLiang Ye
Liang Ye
Renal fibrosis is a critical step in chronic kidney disease (CKD) progression, but fibrosis induction is still not understood well. We found that IFN-λ is a profibrotic factor that is upregulated in fibrotic human and mouse kidneys. IFN-λ receptor deficiency ameliorated renal fibrosis in mice while exogenous IFN-λ exacerbated disease, establishing a detrimental role of IFN-λ signaling in renal fibrosis. Mechanistically, we found that IFN-λ promotes fibrosis by preferentially acting on renal fibroblasts, inducing their activation and migration through ERK/JNK-dependent synthesis of TGF-β and activation of the TGF-β-SMAD2/3 signaling pathway. Renal tubular epithelial cell (TEC)-derived IFN-λ induced by RIG-I/MAVS signaling emerged as a critical driver of renal fibroblast activation and fibrogenesis. Importantly, neutralizing antibodies against IFN-λ strongly attenuated renal fibrosis in mice. Thus, the renal TEC-IFN-λ-fibroblast axis is a previously unrecognized pathway of renal fibrosis induction that represents an attractive novel target for mitigating CKD progression.